Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of experimental RNAi therapeutics is focused across three strategic therapeutic ...

Burjeel Medical City, under the guidance of the Department of Health – Abu Dhabi (DoH), has administered Givosiran for the ... acute intermittent hepatic porphyria, a rare genetic disorder ...